Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 65 Neoplasms 56 Prostatic Neoplasms 44 Lung Neoplasms 35 Colorectal Neoplasms 35 Carcinoma, Non-Small-Cell Lung 24 Pancreatic Neoplasms 21 Hematologic Neoplasms 19 Head and Neck Neoplasms 16 Neoplasm Metastasis 15 Urinary Bladder Neoplasms 12 Ovarian Neoplasms 11 Stomach Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 10 Motor Activity 10 Triple Negative Breast Neoplasms 9 Multiple Myeloma 9 Colonic Neoplasms 9 Melanoma 8 Glioma 8 Anxiety Disorders 8 Uterine Cervical Neoplasms 7 Hematopoietic and Lymphatic System Neoplasm 7 Glioblastoma 7 Gastrointestinal Neoplasms 7 Esophageal Neoplasms 7 Anatomic Stage I Breast Cancer AJCC v8 7 Smoking Cessation 6 Sarcoma 6 Rectal Neoplasms 6

Interventions

Peripheral Blood Stem Cell Transplantation 36 fludarabine phosphate 32 Cyclophosphamide 30 Mycophenolic Acid 26 Whole-Body Irradiation 23 Tacrolimus 22 Cyclosporine 20 Busulfan 16 Antilymphocyte Serum 16 Methotrexate 14 Radiotherapy 13 Filgrastim 12 Flow Cytometry 11 Etoposide 11 Methylprednisolone 8 Melphalan 8 Therapeutics 7 Rituximab 7 Lenalidomide 7 Psychiatric Rehabilitation 6 Cord Blood Stem Cell Transplantation 6 Bortezomib 6 Transplantation 5 Sirolimus 5 Polymerase Chain Reaction 5 Gemcitabine 5 Everolimus 5 Brentuximab Vedotin 5 Alemtuzumab 5 pembrolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Sezary Syndrome × Standard of Care × Clear all

NCT05206045 2022-01-25

SURPASSe

Assistance Publique - Hôpitaux de Paris

Sezary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡